Next Article in Journal
Influence of Carbon Sources on Biomass and Biomolecule Accumulation in Picochlorum sp. Cultured under the Mixotrophic Condition
Next Article in Special Issue
The Acute Effects of Single or Repeated Bouts of Vigorous-Intensity Exercise on Insulin and Glucose Metabolism during Postprandial Sedentary Behavior
Previous Article in Journal
The Impact of School Meal Programs on Educational Outcomes in African Schoolchildren: A Systematic Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Association between Cardiorespiratory Fitness and Metabolic Syndrome in Korean Older Adults

Department of Smart Information Communication Engineering, Sangmyung University, Cheonan 330-720, Korea
Int. J. Environ. Res. Public Health 2022, 19(6), 3671; https://doi.org/10.3390/ijerph19063671
Submission received: 5 February 2022 / Revised: 14 March 2022 / Accepted: 18 March 2022 / Published: 19 March 2022
(This article belongs to the Special Issue Cardiorespiratory Fitness and Its Health Implications)

Abstract

:
Background: Little is known about the relationship between non-exercise-based estimation of cardiorespiratory fitness (eCRF) and metabolic syndrome (MetS) in Korea. The current study examined the prognostic role of eCRF in the risk stratification of MetS in a representative sample of Korean older adults (1822 men and 3069 women). Methods: The data used in the current study were extracted from the Korea National Health and Nutrition Examination Surveys IV and V. eCRF was obtained using a previously validated algorithm. MetS was defined according to the National Cholesterol Education Program definition with the acceptance of a Korean-specific waist circumference cutoff point. Results: Lower eCRF was significantly correlated with abnormalities in several components of MetS, including abdominal obesity, elevated glucose, elevated triglycerides, and decreased high-density lipoprotein cholesterol. Furthermore, there was an inverse linear relationship between MetS prevalence and eCRF levels; higher eCRF was significantly and independently associated with lower prevalence of MetS. Conclusion: The current findings suggest that eCRF can be adopted as a prognostic measure in determining the risk for MetS for elderly persons.

1. Introduction

Metabolic syndrome (MetS) represents the preclinical feature of clustered metabolic risk factors that contributes to an increased risk for type 2 diabetes (T2D) and/or cardiovascular disease (CVD) in both developed and developing countries [1,2]. Components of MetS include central obesity, elevated blood pressure, elevating fasting glucose, elevated triglycerides, and decreased high-density lipoprotein cholesterol [3]. Etiologically, excessive caloric intake and physical inactivity have been considered as two major modifiable risk factors for the global epidemic of MetS [4]. The relationships between obesity and physical inactivity and/or poor physical fitness with MetS have been observed in Korean adults [5,6,7].
Cardiorespiratory fitness (CRF) reflects the respiratory and circulatory capacity of delivering oxygen into skeletal muscles for energy production during sustained physical activity. The prognostic role of CRF for the prediction of MetS has been substantially and consistently reported in the literature [8,9]. However, the needs for an ergometer, a metabolic cart, trained personnel, sufficient time, and others limit the objective measurement of CRF, especially among elderly persons.
Alternatively, CRF can be estimated using regularly checked health parameters with an acceptable accuracy [10,11], and non-exercise-based estimation of CRF (eCRF) has a prognostic value for the prediction of morbidity and mortality in different populations [12,13]. Furthermore, eCRF is inversely associated with the risk of non-alcoholic fatty liver disease (NAFLD) in Korean adults [14].
One-third of Korean adults suffer from MetS, and the prevalence of MetS is on the rise with advanced age [15]. In South Korea, population aging is growing at the fastest pace among the Organization for Economic Co-operation and Development (OECD) countries (https://data.oecd.org/pop/elderly-population.htm (accessed on 7 September 2021)), implying a substantial health burden and medical cost to Korean society. Therefore, considering its steadily rising prevalence in the face of a rapidly aging society, MetS will continue to represent a key public health issue in South Korea, especially among elderly Koreans.
To the best of our knowledge, only a handful of studies have reported an association between eCRF and MetS in Korean populations [16,17]. The association is not available for older adults from South Korea. Therefore, the aim of this study was to examine the association between eCRF and MetS in older Korean adults.

2. Materials and Methods

2.1. Database Source and Study Participants

The data used in the current study were extracted from the Korea National Health and Nutrition Examination Surveys (KNHANES) IV and V, which were conducted in South Korea from 2008 to 2011 to assess the health-related behaviors, health conditions, and nutritional status of Koreans. A detailed description of the surveys is available elsewhere (http://knhanes.cdc.go.kr/, accessed 3 May 2021). The current study included 1822 men and 3069 women aged 60 years and older (n = 4891). Individuals with no data available regarding the components of MetS (133 men and 277 women) were excluded. Consequently, 1689 men and 2792 women (n = 4481) were included in the final data analyses (Figure 1). The Institutional Review Board of the Korea Center for Disease Control and Prevention reviewed and approved the KNHANES protocols (Nos. 2008-04EXP-01-C, 2009-01CON-03-2C, 2010-02CON-21-C, 2011-02CON-06C).

2.2. Study Variables

2.2.1. Definition of Metabolic Syndrome (MetS)

MetS was defined according to the following criteria [1] with the acceptance of Korean-specific waist circumference (WC) criteria [18]: (a) abdominal obesity (WC ≥ 90 cm for men and WC ≥ 85 cm for women); (b) elevated TG (TG ≥ 150 mg/dL) or medication use; (c) low HDL-C (HDLC < 40 mg/dL for men and HDLC < 50 mg/dL for women) or medication use; (d) elevated resting blood pressure (SBP ≥ 130 mmHg and/or DBP ≥ 85 mmHg) or use of antihypertensive agents; and (e) elevated fasting glucose (glucose ≥ 100 mg/dL) or use of anti-diabetic medication.

2.2.2. Estimation of Cardiorespiratory Fitness (eCRF)

eCRF was obtained using a previously validated regression equation [11]; eCRF (mL·kg−1·min−1) = 2.77 × (0 for men, 1 for women) − 0.10 × (age) − 0.17 × (body mass index) − 0.03 × (resting heart rate) + 1.00 × (physical activity score) + 18.07. Physical activity scores were assessed using the Johnson Space Center physical activity rating scale [19]. Individual eCRF values were categorized as low (lowest 25 percentile), middle (middle 50 percentile), and high (highest 25 percentile).

2.2.3. Clinical and Laboratory Measurements

A standardized questionnaire was used to assess health behaviors and socioeconomic status, including smoking, alcohol consumption, physical activity, income, marital status, education, and past medical history. Systolic blood pressure (SBP), diastolic blood pressure (DBP), and resting heart rate (RHR) were also measured using a standardized protocol. WC was measured midway between the highest point of the iliac crest and the bottom of the ribcage. Body mass index (BMI) was calculated as weight (kg) divided by height (m2). A detailed description of the clinical measurements is available elsewhere [16].
Blood samples were collected from the anterior cubital vein after overnight fasting for the assessments of glucose, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDLC), insulin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and vitamin D. The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated; HOMA-IR = fasting insulin (U/L) × fasting glucose (nmol/L)/22.5. A detailed explanation of the laboratory measurements is available elsewhere [20].

2.3. Statistics

Prior to statistical analyses, a normality check for all variables was conducted with the Kolmogorov–Smirnov test, and an appropriate transformation was performed if necessary. All data are presented as means and standard deviations for continuous variables and as percentages for categorical variables. Parametric and non-parametric statistics were used to compare continuous and categorical variables, respectively. Logistic regression analyses were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Alpha was set at 0.05. All statistical analyses were performed using SPSS-PC statistical software (version 27.0, SPSS, Inc., Chicago, IL, USA).

3. Results

Table 1 describes the characteristics of the study participants. Prevalence of MetS was 38.5% (n = 1882) in total, 34.5% in men (n = 583), and 46.5 (n = 1299) in women (p < 0.001 for gender).
Men with MetS were younger, had higher values of BMI (p = 0.001), percentage body fat (p < 0.001), WC (p < 0.001), SBP (p < 0.001), and DBP (p < 0.001) in conjunction with lower levels of eCRF (p < 0.001) and educational background (p = 0.003) compared to men without MetS. Men with MetS had higher rates of hypertension and diabetes in conjunction with less favorable blood chemistry profiles compared to men without MetS.
Likewise, women with MetS were older (p = 0.002), had higher values of BMI (p < 0.001), percentage body fat (p < 0.001), WC (p < 0.001), RHR (p < 0.001), SBP (p < 0.001), and DBP (p < 0.001) in conjunction with lower levels of eCRF (p < 0.001) and educational background (p < 0.001) compared to women without MetS. Women with MetS had higher rates of hypertension (p < 0.001) and diabetes (p < 0.001) in conjunction with less favorable blood chemistry profiles compared to women without MetS.
In total, individuals with MetS had higher levels of BMI (p < 0.001), percentage body fat (p < 0.001), WC (p < 0.001), SBP (p < 0.001), DBP (p < 0.001), hypertension (p < 0.001), diabetes (p < 0.001), and had lower levels of eCRF (p < 0.001), educational background (p < 0.001), and having a spouse (p < 0.001) compared to individuals without MetS. In addition, individuals with MetS had less favorable blood chemistry profiles compared to individuals without MetS. Together, the current findings suggest that regardless of gender, individuals with MetS had higher body fatness and lower cardiorespiratory fitness in conjunction with less favorable blood chemistry profiles compared to individuals without MetS.
Table 2 shows the associations between eCRF and measured parameters. In men, there were decremental linear trends in age (p < 0.001), BMI (p < 0.001), percentage body fat (p < 0.001), WC (p < 0.001), SBP (p < 0.001), and DBP (p = 0.046) across the incremental eCRF quantile (from low to high). There were incremental linear trends in income (p = 0.007), marriage (p < 0.001), educational background (p < 0.001), and decremental linear trends in smoking (p < 0.001), alcohol consumption (p = 0.039), hypertension (p = 0.011), and diabetes (p = 0.005) by eCRF levels. There were decremental linear trends in fasting blood glucose (p = 0.018), insulin (p < 0.001), HOMA-IR (p < 0.001), TG (p = 0.002), and the prevalence of MetS (p < 0.001) in conjunction with incremental linear trends in HDLC (p < 0.001) and vitamin D (p < 0.001) by eCRF levels. No such linear trends were found in DBP, TC, TC, AST, and ALT by eCRF levels.
In women, there were significant decremental linear trends in age (p < 0.001), BMI (p < 0.001), percentage body fat (p < 0.001), WC (p < 0.001), and SBP (p < 0.001) according to incremental eCRF quantile (from low to high). There were incremental linear trends in marriage (p < 0.001) and educational background (p < 0.001), and decremental linear trends in hypertension (p < 0.001) and diabetes (p = 0.009) across incremental eCRF levels (from low to high). There were decremental linear trends in fasting blood glucose (p < 0.001), insulin (p < 0.001), HOMA-IR (p < 0.001), TG (p < 0.001), and the prevalence of MetS (p < 0.001) in conjunction with incremental linear trends in HDLC (p < 0.001) and vitamin D (p < 0.001) by eCRF levels. No such linear trends were found in DBP, income, smoking, alcohol consumption, TC, AST, and ALT by eCRF levels.
In total, there were decremental linear trends in age (p < 0.001), BMI (p < 0.001), percentage a body fat (p < 0.001), WC (p < 0.001), SBP (p < 0.001), and DBP (p = 0.046) across the incremental eCRF quantile (from low to high). There were incremental linear trends in marriage (p < 0.001), educational background (p < 0.001), and decremental linear trends in the prevalence of hypertension (p < 0.001) and diabetes (p < 0.001) by eCRF levels. There were decremental linear trends in fasting blood glucose (p < 0.001), insulin (p < 0.001), HOMA-IR (p < 0.001), TG (p < 0.001), AST (p = 0.010), ALT (p < 0.001), and the prevalence of MetS (p < 0.001) in conjunction with incremental linear trends in HDLC (p < 0.001) and vitamin D (p < 0.001) by eCRF levels. No such linear trends were found in household income, smoking, alcohol consumption, and TC by eCRF levels. Together, the current findings suggest that regardless of gender, higher eCRF is associated with better body composition and more favorable profile of metabolic risk factors.
Table 3 represents the odds ratios and 95% confidence intervals of abnormalities in the components of MetS by eCRF quantile. In men, ORs for abnormalities in components of MetS, including abdominal obesity (p < 0.001), elevated fasting glucose (p < 0.001), elevated TG (p < 0.001), and low HDLC (p < 0.001), decreased linearly by incremental eCRF levels (from low to high).
In women, ORs for abnormalities in components of MetS, including abdominal obesity (p < 0.001), elevated fasting glucose (p < 0.001), and elevated TG (p < 0.001), decreased linearly by eCRF levels (from low to high). No such linear trends in hypertension and low HDLC were found by incremental eCRF levels.
In total, ORs for abnormalities in components of MetS, including abdominal obesity (p < 0.001), elevated fasting glucose (p < 0.001), elevated TG (p < 0.001), and low HDLC (p < 0.001), decreased linearly by incremental eCRF levels (from low to high). In general, individuals with higher eCRF were less likely to have abnormalities in several components of MetS, as compared to individuals with lower eCRF. Together, the current findings suggest that higher eCRF is associated with a lower risk for having abnormal components of MetS.
Figure 2 shows an independent association between eCRF and the prevalence of MetS. Overall, there was a decremental linear trend (F(2,3980) = 116.721, p < 0.001) in the prevalence of MetS by incremental eCRF levels (from low to high); regardless of gender, individuals with higher eCRF were less likely to have a MetS diagnosis compared to individuals with lower eCRF.

4. Discussion

This population-based study examined whether eCRF is inversely associated with MetS in Korean older adults and showed that low eCRF was significantly associated with less favorable profiles of MetS risk factors. Low eCRF was associated with abnormalities in several components of MetS in both men and women. Regardless of gender, low eCRF was independently associated with a higher risk for having a MetS diagnosis.
The current findings of this study are consistent with the findings of previous studies involving older adults. In a 2-year follow-up study involving 1226 men and women aged 57–78 years, for example, Hassinen et al. [21] examined the relationship between objectively measured CRF and the development and resolution of MetS and showed that baseline fitness was inversely associated with MetS risk at baseline and higher resolution of MetS over 2 years of follow-up. In a cross-sectional study involving 184 elderly community-dwelling persons aged 60–80 years, Câmara et al. [22] examined the relationships between CRF and muscle strength and MetS and showed that coexistence of low CRF and low muscle strength was an independent predictor of increased MetS risk. Likewise, Arovah et al. [23] examined the relationship between CRF and MetS in a sample of 161 Indonesian middle-aged and older adults and found that low CRF was independently associated with decreased HDL-C, hypertriglyceridemia, and higher MetS prevalence. Taken together, those current and previous findings support the prognostic role of CRF in MetS in geriatric populations.
Even as a well-established risk factor for MetS, CRF is not regularly checked in most healthcare settings because of its impracticality and high cost [24], especially in sedentary elderly persons at risk for mobility disabilities [25]. Alternatively, eCRF can be used as a prognostic tool for risk stratification. For example, in our previous study, we examined the relationship between eCRF and MetS in Korean adults and found that high eCRF was correlated with lower MetS risk [14]. In addition to morbidity, eCRF is associated with premature death from all including specific causes [26,27]. Taken together, those current and previous findings suggest that eCRF has a prognostic value for initial risk stratification in geriatric populations.
The prognostic value of eCRF for MetS diagnosis might reflect the clinical implications of abnormalities in the parameters used for its estimation algorithm, including age, sex, RHR, PA, and BMI. In particular, RHR, PA, and BMI were indicative of healthy lifestyle habits. In a population-based cohort study, Jian et al. [28] examined the association between RHR and MetS and showed that elevated RHR was an independent predictor for MetS diagnosis at baseline and future incidence of MetS in Chinese adults. Likewise, elevated RHR was positively and independently associated with several components of MetS, such as abdominal obesity, hypertension, and hyperglyceridemia, and the presence of MetS in Korean adults [29,30]. In addition to elevated RHR, overweight/obesity and physical inactivity are two well-established risk factors for MetS and related disorders in different populations [31,32].
Several explanations can be given to the protective effect of high eCRF against MetS observed in the current study. First, insulin resistance is a key mechanism underlying MetS pathology. In contrast, high CRF contributes to enhanced insulin sensitivity and/or insulin action in both overweight/obese and normal subjects [33,34]. Second, low-grade inflammation is associated with the etiology of MetS. In contrast, high CRF protects from MetS by suppressing pro-inflammation and enhancing anti-inflammation [35,36]. Lastly, defective mitochondrial biogenesis is another mechanism underlying MetS pathology in skeletal muscle, liver, and pancreas, in conjunction with impaired insulin signaling and glucose metabolism. On the other hand, high CRF protects from MetS by enhancing insulin sensitivity, glucose metabolism, and fatty acid oxidation [37,38].
This study had several limitations. The cross-sectional nature of the current study is a limitation in drawing conclusions regarding causation. The current findings of the study should be confirmed in a cause-and-effect manner by conducting an exercise intervention study. Second, elderly persons are at an especially increased risk of developing MetS due to various physiological mechanisms associated with normal aging, including sarcopenic obesity, lack of physical activity, increased sitting time, and others, which should all be considered in a future study for better delineation of geriatric MetS etiology. Lastly, the gender differences in the relationships between eCRF and specific components of the MetS (i.e., hyperglyceridemia and low HDLC) observed in the current study remain to be further investigated in a future study.

5. Conclusions

In conclusion, we examined the association between eCRF and MetS in a representative sample of Korean older adults and found that low eCRF was significantly and independently correlated with abnormalities in components of MetS and its prevalence. The current findings suggest that maintaining and/or obtaining higher CRF via physical activity may be beneficial for older persons who are at an increased risk for MetS.

Funding

This research received no external funding.

Institutional Review Board Statement

The Institutional Review Board of the Korea Centre for Disease Control and Prevention in accordance with the Declaration of Helsinki reviewed and approved the KNHANES (Nos. 2008-04EXP-01-C, 2009-01CON-03-2C, 2010-02CON-21-C, 2011-02CON-06C).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The datasets used and/or analysed during the current study are available from the corresponding author on request.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Alberti, K.G.M.M.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.T.; Loria, C.M.; Smith, S.C., Jr. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120, 1640–1645. [Google Scholar] [PubMed] [Green Version]
  2. Lee, M.K.; Han, K.; Kim, M.K.; Koh, E.S.; Kim, E.S.; Nam, G.E.; Kwon, H.S. Changes in metabolic syndrome and its components and the risk of type 2 diabetes: A nationwide cohort study. Sci. Rep. 2020, 10, 2313. [Google Scholar] [CrossRef] [PubMed]
  3. Tune, J.D.; Goodwill, A.G.; Sassoon, D.J.; Mather, K.J. Cardiovascular consequences of metabolic syndrome. Transl. Res. 2017, 183, 57–70. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Saklayen, M.G. The Global Epidemic of the Metabolic Syndrome. Curr. Hypertens. Rep. 2018, 2, 12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Lee, S.H.; Seo, J.H.; Kim, Y.A. Association between exercise and metabolic syndrome in Koreans. J. Obes. Metab. Syndr. 2018, 27, 117–124. [Google Scholar] [CrossRef] [PubMed]
  6. Oh, S.W. Obesity and metabolic syndrome in Korea. Diabetes Metab. J. 2011, 35, 561–566. [Google Scholar] [CrossRef] [Green Version]
  7. Son, K.Y.; Shin, D.W.; Lee, J.E.; Kim, S.H.; Yun, J.M.; Cho, B. Association of metabolic syndrome with mobility in the older adults: A Korean nationwide representative cross-sectional study. Sci. Rep. 2021, 11, 6605. [Google Scholar] [CrossRef]
  8. Myers, J.; McAuley, P.; Lavie, C.J.; Despres, J.-P.; Arena, R.; Kokkinos, P. Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: Their independent and interwoven importance to health status. Prog. Cardiovasc. Dis. 2015, 57, 306–314. [Google Scholar] [CrossRef]
  9. Swift, D.L.; Lavie, C.J.; Johannsen, N.M.; Arena, R.; Earnest, C.P.; O’ Keefe, J.H.; Milani, R.V.; Blair, S.N.; Church, T.S. Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ. J. 2013, 77, 281–292. [Google Scholar] [CrossRef] [Green Version]
  10. Wang, Y.; Chen, S.; Zhang, J.; Zhang, Y.; Ernstsen, L.; Lavie, C.J.; Hooker, S.P.; Chen, Y.; Sui, X. Nonexercise estimated cardiorespiratory fitness and all-cancer mortality: The NHANES III Study. Mayo Clin. Proc. 2018, 93, 848–856. [Google Scholar] [CrossRef]
  11. Jurca, R.; Jackson, A.S.; LaMonte, M.J.; Morrow, J.R., Jr.; Blair, S.N.; Wareham, N.J.; Haskell, W.L.; van Mechelen, W.; Church, T.S.; Jakicic, J.M.; et al. Assessing cardiorespiratory fitness without performing exercise testing. Am. J. Prev. Med. 2005, 29, 185–193. [Google Scholar] [CrossRef] [PubMed]
  12. Song, M.; Lee, I.; Kang, H. Cardiorespiratory fitness without exercise testing can predict all-cause mortality risk in a representative sample of Korean older adults. Int. J. Environ. Res. Public Health 2019, 16, 1633. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Christensen, R.A.G.; Arneja, J.; St Cyr, K.; Sturrock, S.L.; Brooks, J.D. The association of estimated cardiorespiratory fitness with COVID-19 incidence and mortality: A cohort study. PLoS ONE 2021, 16, e0250508. [Google Scholar] [CrossRef] [PubMed]
  14. Lee, I.; Kim, S.; Kang, H. Non-exercise based estimation of cardiorespiratory fitness is inversely associated with metabolic syndrome in a representative sample of Korean adults. BMC Geriatr. 2020, 20, 146. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Lee, I.; Kim, J.; Kang, H. Estimated cardiorespiratory fitness attenuates the impacts of sarcopenia and obesity on non-alcoholic fatty liver in Korean adults. Int. J. Environ. Res. Public Health 2020, 17, 3902. [Google Scholar] [CrossRef] [PubMed]
  16. Lee, S.E.; Han, K.; Kang, Y.M.; Kim, S.O.; Cho, Y.K.; Ko, K.S.; Park, J.Y.; Lee, K.U.; Koh, E.H. Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009–2013). PLoS ONE 2018, 13, e0194490. [Google Scholar]
  17. Hong, S.; Lee, J.; Park, J.; Lee, M.; Kim, J.Y.; Kim, K.C.; Kim, S.H.; Im, J.A.; Chu, S.H.; Suh, S.H.; et al. Association between cardiorespiratory fitness and the prevalence of metabolic syndrome among Korean adults: A cross sectional study. BMC Public Health 2014, 14, 481. [Google Scholar] [CrossRef] [Green Version]
  18. Lee, S.Y.; Park, H.S.; Kim, D.J.; Han, J.H.; Kim, S.M.; Cho, G.J.; Kim, D.Y.; Kwon, H.S.; Kim, S.R.; Lee, C.B.; et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res. Clin. Pract. 2007, 75, 72–80. [Google Scholar] [CrossRef]
  19. Ross, R.M.; Jackson, A.S. Exercise Concepts, Calculations, and Computer Applications; Benchmark Press: Carmel, IN, USA, 1990. [Google Scholar]
  20. Kweon, S.; Kim, Y.; Jang, M.J.; Kim, Y.; Kim, K.; Choi, S.; Chun, C.; Khang, Y.H.; Oh, K. Data resource profile: The Korea National Health and Nutrition Examination Survey (KNHANES). Int. J. Epidemiol. 2014, 43, 69–77. [Google Scholar] [CrossRef] [Green Version]
  21. Hassinen, M.; Lakka, T.A.; Hakola, L.; Savonen, K.; Komulainen, P.; Litmanen, H.; Kiviniemi, V.; Kouki, R.; Heikkilá, H.; Rauramaa, R. Cardiorespiratory fitness and metabolic syndrome in older men and women: The dose responses to Exercise Training (DR’s EXTRA) study. Diabetes Care 2010, 33, 1655–1657. [Google Scholar] [CrossRef] [Green Version]
  22. Câmara, M.; Browne, R.A.V.; Souto, G.C.; Schwade, D.; Lucena Cabral, L.P.; Macêdo, G.A.D.; Farias-Junior, L.F.; Gouveia, F.L.; Lemos, T.M.A.M.; Lima, K.C.; et al. Independent and combined associations of cardiorespiratory fitness and muscle strength with metabolic syndrome in older adults: A cross-sectional study. Exp. Gerontol. 2020, 135, 110923. [Google Scholar] [CrossRef] [PubMed]
  23. Arovah, N.I.; Heesch, K.C. The association between cardiorespiratory fitness and metabolic syndrome diagnosis: A cross-sectional study in Indonesian middle-aged and older adults. Phys. Act. Rev. 2021, 9, 101–110. [Google Scholar] [CrossRef]
  24. Clasey, J.; Adams, A.M.; Geiger, P.J.; Segerstrom, S.C.; Crofford, L.J. Estimation of cardiorespiratory fitness without exercise testing: Cross-validation in midlife and older women. Women’s Health Rep. 2020, 1, 584–591. [Google Scholar] [CrossRef]
  25. Church, T.S.; Gill, T.M.; Newman, A.B.; Blair, S.N.; Earnest, C.P.; Pahor, M. Maximal fitness testing in sedentary elderly at substantial risk of disability: LIFE-P study experience. J. Aging Phys. Act. 2008, 16, 408–415. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Stamatakis, E.; Hamer, M.; O’Donovan, G.; Batty, G.D.; Kivimaki, M. A non-exercise testing method for estimating cardiorespiratory fitness: Associations with all-cause and cardiovascular mortality in a pooled analysis of eight population-based cohorts. Eur. Heart J. 2013, 34, 750–758. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Zhang, Y.; Zhang, J.; Zhou, J.; Ernstsen, L.; Lavie, C.J.; Hooker, S.P.; Sui, X. Nonexercise estimated cardiorespiratory fitness and mortality due to all causes and cardiovascular disease: The NHANES III Study. Mayo Clin. Proc. Innov. Qual. Outcomes 2017, 1, 16–25. [Google Scholar] [CrossRef] [PubMed]
  28. Jiang, X.; Liu, X.; Wu, S.; Zhang, G.Q.; Peng, M.; Wu, Y.; Zheng, X.; Ruan, C.; Zhang, W. Metabolic syndrome is associated with and predicted by resting heart rate: A cross-sectional and longitudinal study. Heart 2015, 101, 44–49. [Google Scholar] [CrossRef] [PubMed]
  29. Kang, S.J.; Ha, G.C.; Ko, K.J. Association between resting heart rate, metabolic syndrome and cardiorespiratory fitness in Korean male adults. J. Exerc. Sci. Fit. 2017, 15, 27–31. [Google Scholar] [CrossRef]
  30. Lee, C.; Lee, J.; Jeon, J.Y. The relationship between resting heart rate and risk factors of metabolic syndrome in Korean adults. Korean J. Obes. 2013, 22, 222–230. [Google Scholar] [CrossRef]
  31. Börnhorst, C.; Russo, P.; Veidebaum, T.; Tornaritis, M.; Molnár, D.; Lissner, L.; Mårild, S.; De Henauw, S.; Moreno, L.A.; Floegel, A.; et al. The role of lifestyle and non-modifiable risk factors in the development of metabolic disturbances from childhood to adolescence. Int. J. Obes. 2020, 44, 2236–2245. [Google Scholar] [CrossRef]
  32. Carnethon, M.R.; Loria, C.M.; Hill, J.O.; Sidney, S.; Savage, P.J.; Liu, K. Risk factors for the metabolic syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985–2001. Diabetes Care 2004, 27, 2707–2715. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Haufe, S.; Engeli, S.; Budziarek, P.; Utz, W.; Schulz-Menger, J.; Hermsdorf, M.; Wiesner, S.; Otto, C.; Haas, V.; de Greiff, A.; et al. Cardiorespiratory fitness and insulin sensitivity in overweight or obese subjects may be linked through intrahepatic lipid content. Diabetes 2010, 59, 1640–1647. [Google Scholar] [CrossRef] [Green Version]
  34. Sabag, A.; Keating, S.E.; Way, K.L.; Sultana, R.N.; Lanting, S.M.; Twigg, S.M.; Johnson, N.A. The association between cardiorespiratory fitness, liver fat and insulin resistance in adults with or without type 2 diabetes: A cross-sectional analysis. BMC Sports Sci. Med. Rehabil. 2021, 13, 40. [Google Scholar] [CrossRef] [PubMed]
  35. Hong, S.; Dimitrov, S.; Pruitt, C.; Shaikh, F.; Beg, N. Benefit of physical fitness against inflammation in obesity: Role of beta adrenergic receptors. Brain Behav. Immun. 2014, 39, 113–120. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Midtboe, H.; Ulvik, A.; Meyer, K.; Ueland, P.M.; Halland, H.; Gerdts, E. Fitness is associated with lower inflammatory markers in obesity: The FATCOR study. Eur. Heart J. 2020, 41, ehaa946.2764. [Google Scholar] [CrossRef]
  37. Cuthbertson, D.J.; Bowden Davies, K. Higher levels of cardiorespiratory fitness keep liver mitochondria happy! J. Physiol. 2017, 595, 5719–5720. [Google Scholar] [CrossRef] [PubMed]
  38. Ren, J.; Pulakat, L.; Whaley-Connell, A.; Sowers, J.R. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J. Mol. Med. 2010, 88, 993–1001. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. A flowchart for selection of study participants.
Figure 1. A flowchart for selection of study participants.
Ijerph 19 03671 g001
Figure 2. The association between estimated cardiorespiratory fitness and the prevalence of metabolic syndrome. Odds ratio (OR) adjusted for age, sex (total), income, education, marital status, smoking, and alcohol intake.
Figure 2. The association between estimated cardiorespiratory fitness and the prevalence of metabolic syndrome. Odds ratio (OR) adjusted for age, sex (total), income, education, marital status, smoking, and alcohol intake.
Ijerph 19 03671 g002
Table 1. Description of study participants by metabolic syndrome status.
Table 1. Description of study participants by metabolic syndrome status.
MetS (men)p ValueMetS (Women)p ValueMetS (Total)p Value
Absence
(n = 1106)
Presence
(n = 583)
Absence
(n = 1493)
Presence
(n = 1299)
Absence
(n = 2599)
Presence
(n = 1882)
Anthropometrics/hemodynamics
 Age (year)69.5 ± 6.368.5 ± 6.10.00168.8 ± 6.469.6 ± 6.10.00269.1 ± 6.469.2 ± 6.10.522
 BMI (kg/m2)22.5 ± 2.725.1 ± 2.6<0.00123.1 ± 2.925.6 ± 3.2<0.00122.8 ± 2.825.5 ± 3.0<0.001
 Body fat (%)21.3 ± 5.325.3 ± 4.6<0.00132.6 ± 5.935.9 ± 4.9<0.00127.8 ± 8.032.6 ± 6.9<0.001
 WC (cm)81.9 ± 8.790.7 ± 7.4<0.00179.1 ± 8.388.1 ± 8.4<0.00180.3 ± 8.588.9 ± 8.2<0.001
 RHR (beats/min)69.8 ± 9.970.4 ± 9.70.24970.6 ± 9.172.2 ± 9.4<0.00157.6 ± 12.362.3 ± 17.90.004
 SBP (mmHg)126.1 ± 17.4135.6 ± 15.5<0.001125.5 ± 17.1137.1 ± 16.2<0.001125.3 ± 17.3136.4 ± 16.0<0.001
 DBP (mmHg)75.7 ± 9.980.0 ± 9.7<0.00175.2 ± 9.579.4 ± 9.7<0.00175.4 ± 9.779.6 ± 9.7<0.001
 eCRF (METs)9.3 ± 1.68.9 ± 1.5<0.0016.4 ± 1.55.7 ± 1.5<0.0017.6 ± 2.16.7 ± 2.1<0.001
 Socioeconomic status
 Income (10,000 won/month)229 ± 635213 ± 2580.572200 ± 465177 ± 3030.128212.3 ± 544.2188.1 ± 290.30.082
 Marital status, n (%) 0.330 0.088 <0.001
  Married1024 (92.6)531 (91.7) 862 (57.7)696 (53.6) 1886 (72.6)1227 (65.2)
  Widow/divorced80 (7.2)49 (8.4) 625 (41.9)597 (46.0) 705 (27.1)646 (34.3)
  Unmarried2 (0.2)3 (0.2) 6 (0.4)6 (0.5) 8 (0.3)9 (0.5)
 Education, n (%) 0.003 <0.001 <0.001
  Elementary510 (46.1)228 (39.1) 1155 (77.4)1096 (84.4) 1665 (64.1)1324 (70.4)
  Middle/high439 (39.7)281 (48.2) 293 (19.6)185 (14.2) 732 (28.2)466 (24.8)
  College157 (14.2)74 (12.7) 45 (3.0)18 (1.4) 202(7.8)92 (4.9)
Health behaviors and conditions
 Smoking, n (%)905 (81.8)468 (80.3)0.238128 (8.6)115 (8.9)0.4231033 (39.7)583 (31.0)<0.001
 Alcohol, n (%)156 (14.1)72 (12.3)0.177629 (42.1)581 (44.7)0.090785 (30.2)653 (34.7)<0.001
 Hypertension, n (%)384 (34.7)329 (56.4)<0.001584 (39.1)795 (61.2)<0.001968 (46.3)1124 (53.7)<0.001
 Diabetes, n (%)136 (12.3)167 (28.6)<0.001123 (8.2)358 (27.6)<0.001277 (10.8)610 (33.3)<0.001
Blood chemistry profiles
 FBG (mg/dL)98.9 ± 24.5115.5 ± 34.9<0.00195.2 ± 18.0112.2 ± 30.0<0.00196.8 ± 21.1113.6 ± 31.6<0.001
 Insulin (uIU/L)8.5 ± 4.111.8 ± 6.7<0.0019.1 ± 4.612.6 ± 9.1<0.0018.9 ± 4.412.3 ± 8.4<0.001
 HOMA-IR2.1 ± 1.23.4 ± 2.5<0.0012.2 ± 1.23.6 ± 4.1<0.0012.1 ± 1.23.6 ± 3.7<0.001
 TC (mg/dL)181.5 ± 34.1186.3 ± 37.50.008197.2 ± 35.1202.8 ± 38.0<0.001190.5 ± 35.6197.7 ± 38.6<0.001
 HDLC (mg/dL)47.0 ± 10.737.6 ± 7.9<0.00150.4 ± 10.942.1 ± 8.3<0.00148.9 ± 10.940.7 ± 8.5<0.001
 TG (mg/dL)106.4 ± 51.3201.9 ± 110.0<0.001109.9 ± 52.4185.0 ± 94.8<0.001108.4 ± 51.9190.2 ± 100.0<0.001
 AST (IU/L)23.3 ± 7.725.2 ± 12.4<0.00122.5 ± 8.323.3 ± 9.20.02522.9 ± 8.123.9 ± 10.3<0.001
 ALT (IU/L)20.1 ± 10.325.8 ± 15.3<0.00117.9 ± 11.321.2 ± 12.3<0.00118.8 ± 11.022.6 ± 13.5<0.001
 Vitamin D (ng/mL)21.9 ± 7.420.3 ± 7.3<0.00119.2 ± 7.518.6 ± 7.30.02620.4 ± 7.619.1 ± 7.4<0.001
MetS: metabolic syndrome; BMI: body mass index; WC: waist circumference; RHR: resting heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; eCRF: estimated cardiorespiratory fitness; FBG: fasting blood glucose; HOMA-IR: homeostatic model assessment for insulin resistance; TC: total cholesterol; HDLC: high density lipoprotein-cholesterol; TG: triglycerides; AST: aspartate aminotransferase; ALT: alanine aminotransferase.
Table 2. Descriptive statistics of measured parameters by estimated cardiorespiratory fitness.
Table 2. Descriptive statistics of measured parameters by estimated cardiorespiratory fitness.
VariableLevels of eCRF (Men)p for TrendsLevels of eCRF (Women)p for TrendsLevels of eCRF (Total)p for Trends
LowMiddleHighLowMiddleHighLowMiddleHigh
Age (years)75.3 ± 5.868.1 ± 5.566.1 ± 4.9<0.00175.8 ± 5.868.0 ± 5.666.1 ± 4.9<0.00172.1 ± 7.669.1 ± 6.168.4 ± 5.9<0.001
BMI (kg/m2)24.4 ± 3.023.1 ± 3.022.7 ± 2.7<0.00125.6 ± 3.823.8 ± 3.123.6 ± 2.9<0.00126.3 ± 3.223.5 ± 3.022.7 ± 2.7<0.001
BF (%)25.2 ± 5.222.4 ± 5.320.9 ± 5.2<0.00136.1 ± 5.733.9 ± 5.532.7 ± 5.9<0.00133.2 ± 7.229.7 ± 7.727.8 ± 8.1<0.001
WC (cm)88.0 ± 8.984.4 ± 9.682.3 ± 8.4<0.00187.2 ± 10.082.3 ± 8.780.9 ± 8.8<0.00190.1 ± 9.082.9 ± 8.980.1 ± 8.3<0.001
SBP131.6 ± 16.9127.5 ± 17.1127.5 ± 17.5<0.001134.4 ± 17.5130.4 ± 17.7128.3 ± 17.7<0.001132.3 ± 17.2129.7 ± 17.7128.6 ± 17.5<0.001
DBP76.2 ± 9.977.5 ± 10.077.7 ± 10.00.05876.8 ± 10.277.1 ± 9.877.0 ± 10.00.71077.8 ± 9.977.0 ± 10.676.7 ± 10.10.046
Income (10,000 won/month)154 ± 439228 ± 527285 ± 7760.007228 ± 758224 ± 1413187 ± 2560.713196.3 ± 452.9230.5 ± 1123.1205.2 ± 554.70.576
Marital status, n (%) <0.001 <0.001 <0.001
 Married342 (86.4)727 (93.0)384 (94.3) 239 (33.7)832 (59.0)464 (65.7) 515 (58.5)1832 (69.2)641 (72.8)
 Widow/divorced54 (13.6)61 (6.5)22 (5.4) 466 (65.7)573 (40.7)240 (34.0) 363 (41.2)808 (30.5)235 (26.7)
 Unmarried0 (0)4 (0.5)1 (0.2) 4 (0.6)4 (0.3)2 (0.3) 2 (0.2)9 (0.3)4 (0.5)
Education, n (%) <0.001 <0.001 <0.001
 Elementary218 (55.1)340 (43.5)148 (36.4) 637 (89.8)1125 (79.8)546 (77.3) 669 (76.0)1756 (66.3)589 (56.9)
 Middle/high133 (33.6)350 (44.8)186 (45.7) 69 (9.7)248 (17.6)138 (19.5) 712 (19.5)724 (27.3)228 (25.9)
 College45 (11.4)92 (11.8)73 (17.9) 3 (0.4)36 (2.6)22 (3.1) 39 (4.4)169 (6.4)63 (7.2)
Smoking, n (%)88 (12.4)115 (8.2)40 (5.7)<0.001320 (80.8)641 (82.0)324 (79.6)0.607296 (33.6)948 (35.8)284 (32.3)0.128
Alcohol, n (%)343 (48.4)809 (42.6)396 (43.9)0.03966 (16.7)103 (13.2)51 (12.5)0.172318 (36.1)860 (32.5)295 (33.5)0.135
Hypertension, n (%)448 (63.2)677 (48.0)290 (41.1)0.011202 (51.0)321 (41.0)143 (35.1)<0.001522 (59.3)1207 (45.6)352 (40.0)<0.001
Diabetes, n (%)154 (21.7)236 (16.7)100 (14.2)0.00587 (22.0)153 (19.6)53 (13.0)0.009214 (29.4)470 (19.5)127 (15.3)<0.001
FBG (mg/dL)107.9 ± 33.4106.5 ± 33.2101.9 ± 23.20.018108.5 ± 30.3102.2 ± 25.5101.1 ± 23.4<0.001109.9 ± 32.2103.7 ± 28.2100.2 ± 21.6<0.001
Insulin (uIU/L)11.8 ± 7.99.2 ± 4.18.5 ± 3.5<0.00112.8 ± 12.410.4 ± 5.49.7 ± 4.4<0.00112.6 ± 7.410.2 ± 7.28.8 ± 3.6<0.001
HOMA-IR3.2 ± 2.82.5 ± 1.62.2 ± 1.1<0.0013.6 ± 5.62.7 ± 2.02.5 ± 1.5<0.0013.5 ± 2.72.7 ± 3.12.2 ± 1.2<0.001
TC (mg/dL)183.5 ± 35.0184.8 ± 35.3183.6 ± 36.70.808202.1 ± 37.5199.2 ± 36.1200.0 ± 36.30.300195.5 ± 38.4194.5 ± 36.7192.7 ± 36.50.294
HDLC (mg/dL)41.7 ± 10.443.2 ± 10.646.1 ± 11.0<0.00145.2 ± 9.746.6 ± 10.747.6 ± 10.8<0.00143.5 ± 10.145.6 ± 10.846.8 ± 10.8<0.001
TG (mg/dL)145.5 ± 86.6145.1 ± 92.9127.1 ± 83.90.002153.0 ± 74.2146.7 ± 87.3135.3 ± 79.1<0.001161.9 ± 97.9142.9 ± 81.0128.4 ± 81.5<0.001
AST (IU/L)23.6 ± 8.224.2 ± 11.224.0 ± 7.90.64823.0 ± 8.222.7 ± 7.723.4 ± 10.90.20224.1 ± 9.323.0 ± 8.723.5 ± 10.20.010
ALT (IU/L)22.4 ± 13.322.7 ± 13.721.0 ± 9.30.09219.3 ± 11.319.2 ± 10.320.1 ± 14.90.24323.0 ± 13.919.9 ± 11.119.7 ± 13.5<0.001
Vitamin D (ng/mL)20.0 ± 7.121.4 ± 7.622.8 ± 7.5<0.00117.8 ± 7.319.0 ± 7.420.0 ± 7.8<0.00118.9 ± 7.419.7 ± 7.421.2 ± 8.0<0.001
MetS, n (%)376 (64.3)579 (44.2)252 (37.0)<0.001376 (64.3)579 (44.2)252 (37.0<0.001464 (61.9)997 (40.5)264 (31.3)<0.001
BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; HOMA-IR: homeostatic model assessment for insulin resistance; TC: total cholesterol; HDLC: high density lipoprotein-cholesterol; TG: triglycerides; AST: aspartate aminotransferase; ALT: alanine aminotransferase; MetS: metabolic syndrome.
Table 3. Odds ratios (ORs) and 95% confidence intervals (CIs) for abnormal components of metabolic syndrome by estimated cardiorespiratory fitness.
Table 3. Odds ratios (ORs) and 95% confidence intervals (CIs) for abnormal components of metabolic syndrome by estimated cardiorespiratory fitness.
ComponentsLevels of eCRF (Men)pLevels of eCRF (Women)pLevels of eCRF (Total)p
LowMiddleHighLowMiddleHighLowMiddleHigh
Abdominal obesity10.261
(0.191–0.358)
0.131
(0.089–0.197)
<0.00110.185
(0.146–0.235)
0.138
(0.105–0.182)
<0.00110.277
(0.191–0.270)
0.123
(0.098–0.153)
<0.001
Hypertension10.825
(0.625–1.088)
0.938
(0.677–1.302)
0.30110.862
(0.696–1.069)
0.744
(0.581– 0.953)
0.06010.938
(0.800–1.099)
0.896
(0.738–1.087)
0.055
Hyperglycemia10.661
(0.493–0.887)
0.474
(0.335– 0.670)
<0.00110.460
(0.364–0.580)
0.417
(0.319– 0.544)
<0.00110.569
(0.481–0.674)
0.469
(0.382–0.576)
<0.001
Hypertriglyceridemia10.630
(0.462–0.858)
0.347
(0.239–0.504)
<0.00110.708
(0.562–0.891)
0.502
(0.384–0.657)
<0.00110.653
(0.551–0.774)
0.406
(0.327–0.503)
<0.001
Low HDLC10.591
(0.441–0.792)
0.411
(0.291–0.582)
<0.00110.970
(0.761–1.238)
0.901
(0.685–1.187)
0.69610.738
(0.617–0.882)
0.677
(0.547–0.837)
<0.001
HDLC: high density lipoprotein-cholesterol. ORs adjusted for age, sex, income, education, marital status, smoking, and alcohol intake.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kim, S. Association between Cardiorespiratory Fitness and Metabolic Syndrome in Korean Older Adults. Int. J. Environ. Res. Public Health 2022, 19, 3671. https://doi.org/10.3390/ijerph19063671

AMA Style

Kim S. Association between Cardiorespiratory Fitness and Metabolic Syndrome in Korean Older Adults. International Journal of Environmental Research and Public Health. 2022; 19(6):3671. https://doi.org/10.3390/ijerph19063671

Chicago/Turabian Style

Kim, Shinuk. 2022. "Association between Cardiorespiratory Fitness and Metabolic Syndrome in Korean Older Adults" International Journal of Environmental Research and Public Health 19, no. 6: 3671. https://doi.org/10.3390/ijerph19063671

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop